159 related articles for article (PubMed ID: 37623195)
1. Effectiveness of Clinic-Based Patient-Led Human Papillomavirus DNA Self-Sampling among HIV-Infected Women in Uganda.
Nyabigambo A; Mayega RW; Ginindza TG
Int J Environ Res Public Health; 2023 Aug; 20(16):. PubMed ID: 37623195
[TBL] [Abstract][Full Text] [Related]
2. Facilitators and Barriers to HPV Self-Sampling as a Cervical Cancer Screening Option among Women Living with HIV in Rural Uganda.
Nyabigambo A; Mayega RW; Hlongwana K; Ginindza TG
Int J Environ Res Public Health; 2023 May; 20(11):. PubMed ID: 37297609
[No Abstract] [Full Text] [Related]
3. Prevalence of genital high-risk human papillomavirus infections and associated factors among women living with human immunodeficiency virus in Uganda.
Nakigozi H; Ndejjo R; Bazeyo W; Nabaggala A; Achola C; Iga M; Kalyesubula S; Kanamwangi B; Mutungi G; Batte C; Mukunya D; Sserwanga L; Gemageine G; Oyoo CA; Nabadda S
BMC Cancer; 2024 Feb; 24(1):243. PubMed ID: 38383366
[TBL] [Abstract][Full Text] [Related]
4. Community-based HPV self-collection versus visual inspection with acetic acid in Uganda: a cost-effectiveness analysis of the ASPIRE trial.
Mezei AK; Pedersen HN; Sy S; Regan C; Mitchell-Foster SM; Byamugisha J; Sekikubo M; Armstrong H; Rawat A; Singer J; Ogilvie GS; Kim JJ; Campos NG
BMJ Open; 2018 Jun; 8(6):e020484. PubMed ID: 29895648
[TBL] [Abstract][Full Text] [Related]
5. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
[TBL] [Abstract][Full Text] [Related]
6. Uptake of community-based, self-collected HPV testing vs. visual inspection with acetic acid for cervical cancer screening in Kampala, Uganda: preliminary results of a randomised controlled trial.
Moses E; Pedersen HN; Mitchell SM; Sekikubo M; Mwesigwa D; Singer J; Biryabarema C; Byamugisha JK; Money DM; Ogilvie GS
Trop Med Int Health; 2015 Oct; 20(10):1355-67. PubMed ID: 26031572
[TBL] [Abstract][Full Text] [Related]
7. Comparison of two invitation-based methods for human papillomavirus (HPV) self-sampling with usual care among un- and under-screened Māori, Pacific and Asian women: study protocol for a randomised controlled community trial to examine the effect of self-sampling on participation in cervical-cancer screening.
Brewer N; Bartholomew K; Maxwell A; Grant J; McPherson G; Wihongi H; Bromhead C; Scott N; Crengle S; Cunningham C; Douwes J; Potter JD
BMC Cancer; 2019 Dec; 19(1):1198. PubMed ID: 31815615
[TBL] [Abstract][Full Text] [Related]
8. Acceptability of HPV screening among HIV-infected women attending an HIV-dedicated clinic in Abidjan, Côte d'Ivoire.
Mensah K; Assoumou N; Duchesne V; Pourette D; DeBeaudrap P; Dumont A
BMC Womens Health; 2020 Jul; 20(1):155. PubMed ID: 32723350
[TBL] [Abstract][Full Text] [Related]
9. The preference of women living with HIV for the HPV self-sampling of urine at a rural HIV clinic in Uganda.
Nyabigambo A; Mayega RW; Mendoza H; Shiraz A; Doorbar J; Atuyambe L; Ginindza TG
S Afr J Infect Dis; 2022; 37(1):414. PubMed ID: 36568333
[TBL] [Abstract][Full Text] [Related]
10. Integrated cervical cancer screening in Mayuge District Uganda (ASPIRE Mayuge): a pragmatic sequential cluster randomized trial protocol.
Nakisige C; Trawin J; Mitchell-Foster S; Payne BA; Rawat A; Mithani N; Amuge C; Pedersen H; Orem J; Smith L; Ogilvie G
BMC Public Health; 2020 Jan; 20(1):142. PubMed ID: 32005202
[TBL] [Abstract][Full Text] [Related]
11. Economic Evaluation of Mailed Home-Based Human Papillomavirus Self-sampling Kits for Cervical Cancer Screening.
Meenan RT; Troja C; Buist DSM; Tiro JA; Lin J; Anderson ML; Gao H; Green BB; Winer RL
JAMA Netw Open; 2023 Mar; 6(3):e234052. PubMed ID: 36947040
[TBL] [Abstract][Full Text] [Related]
12. Re-valuation of annual cytology using HPV self-sampling to upgrade prevention (REACH UP): A feasibility study in women living with HIV in the UK.
Cicconi P; Wells C; McCarthy B; Wareing S; Andersson MI; Fox J; Lwanga J; Pal N; Burns F; Woodward C; Malek R; Sabin CA; Dorrell L
HIV Med; 2022 Apr; 23(4):390-396. PubMed ID: 35243750
[TBL] [Abstract][Full Text] [Related]
13. Self-collection based HPV testing for cervical cancer screening among women living with HIV in Uganda: a descriptive analysis of knowledge, intentions to screen and factors associated with HPV positivity.
Mitchell SM; Pedersen HN; Eng Stime E; Sekikubo M; Moses E; Mwesigwa D; Biryabarema C; Christilaw J; Byamugisha JK; Money DM; Ogilvie GS
BMC Womens Health; 2017 Jan; 17(1):4. PubMed ID: 28086933
[TBL] [Abstract][Full Text] [Related]
14. Comparability of self-collected vaginal swabs and physician-collected cervical swabs for detection of human papillomavirus infections in Rakai, Uganda.
Safaeian M; Kiddugavu M; Gravitt PE; Ssekasanvu J; Murokora D; Sklar M; Serwadda D; Wawer MJ; Shah KV; Gray R
Sex Transm Dis; 2007 Jul; 34(7):429-36. PubMed ID: 17075437
[TBL] [Abstract][Full Text] [Related]
15. Study protocol of the CHOiCE trial: a three-armed, randomized, controlled trial of home-based HPV self-sampling for non-participants in an organized cervical cancer screening program.
Tranberg M; Bech BH; Blaakær J; Jensen JS; Svanholm H; Andersen B
BMC Cancer; 2016 Nov; 16(1):835. PubMed ID: 27809810
[TBL] [Abstract][Full Text] [Related]
16. Performance of Cervical Cancer Screening Techniques in HIV-Infected Women in Uganda.
Bansil P; Lim J; Byamugisha J; Kumakech E; Nakisige C; Jeronimo JA
J Low Genit Tract Dis; 2015 Jul; 19(3):215-9. PubMed ID: 25551591
[TBL] [Abstract][Full Text] [Related]
17. Uptake of Cervical Cancer Screening in Ethiopia by Self-Sampling HPV DNA Compared to Visual Inspection with Acetic Acid: A Cluster Randomized Trial.
Gizaw M; Teka B; Ruddies F; Abebe T; Kaufmann AM; Worku A; Wienke A; Jemal A; Addissie A; Kantelhardt EJ
Cancer Prev Res (Phila); 2019 Sep; 12(9):609-616. PubMed ID: 31337647
[TBL] [Abstract][Full Text] [Related]
18. High Prevalence of Cervical High-Grade Lesions and High-Risk Human Papillomavirus Infections in Women Living with HIV: A Case for Prioritizing Cervical Screening in This Vulnerable Group.
Gupta R; Hussain S; Hariprasad R; Dhanasekaran K; Verma S; Agarwal V; Sandeep ; Parveen S; Kaur A; Verma CP; Amita ; Dwivedi R; Singh S; Gupta S
Acta Cytol; 2022; 66(6):496-506. PubMed ID: 35760059
[TBL] [Abstract][Full Text] [Related]
19. Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial.
Lazcano-Ponce E; Lorincz AT; Cruz-Valdez A; Salmerón J; Uribe P; Velasco-Mondragón E; Nevarez PH; Acosta RD; Hernández-Avila M
Lancet; 2011 Nov; 378(9806):1868-73. PubMed ID: 22051739
[TBL] [Abstract][Full Text] [Related]
20. Use of Multiplex Polymerase Chain Reaction for Detection of High-Risk Human Papillomavirus Genotypes in Women Attending Routine Cervical Cancer Screening in Harare.
Marembo T; Dube Mandishora R; Borok M
Intervirology; 2019; 62(2):90-95. PubMed ID: 31412350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
